XML 30 R15.htm IDEA: XBRL DOCUMENT ﻿
v2.3.0.11

Segments of Business and Geographic Areas | 6 Months Ended
--- | ---
Jul. 03, 2011
Segments of Business and Geographic Areas [Abstract] |
SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS | NOTE 9 — SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS SALES BY SEGMENT OF BUSINESS
|  | Fiscal Quarters Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
Consumer |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 1,339 |  |  | $ | 1,463 |  |  |  | (8.5 | )%
International |  |  | 2,454 |  |  |  | 2,184 |  |  |  | 12.4 |
Total |  |  | 3,793 |  |  |  | 3,647 |  |  |  | 4.0 |
Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 3,239 |  |  |  | 3,110 |  |  |  | 4.1 |
International |  |  | 2,994 |  |  |  | 2,443 |  |  |  | 22.6 |
Total |  |  | 6,233 |  |  |  | 5,553 |  |  |  | 12.2 |
Medical Devices & Diagnostics |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 2,869 |  |  |  | 2,865 |  |  |  | 0.1 |
International |  |  | 3,702 |  |  |  | 3,265 |  |  |  | 13.4 |
Total |  |  | 6,571 |  |  |  | 6,130 |  |  |  | 7.2 |
Worldwide |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 7,447 |  |  |  | 7,438 |  |  |  | 0.1 |
International |  |  | 9,150 |  |  |  | 7,892 |  |  |  | 15.9 |
Total |  | $ | 16,597 |  |  | $ | 15,330 |  |  |  | 8.3 | %
|  | Fiscal Six Months Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
Consumer |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 2,684 |  |  | $ | 3,023 |  |  |  | (11.2 | )%
International |  |  | 4,791 |  |  |  | 4,390 |  |  |  | 9.1 |
Total |  |  | 7,475 |  |  |  | 7,413 |  |  |  | 0.8 |
Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 6,630 |  |  |  | 6,316 |  |  |  | 5.0 |
International |  |  | 5,662 |  |  |  | 4,875 |  |  |  | 16.1 |
Total |  |  | 12,292 |  |  |  | 11,191 |  |  |  | 9.8 |
Medical Devices & Diagnostics |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 5,741 |  |  |  | 5,751 |  |  |  | (0.2 | )
International |  |  | 7,262 |  |  |  | 6,606 |  |  |  | 9.9 |
Total |  |  | 13,003 |  |  |  | 12,357 |  |  |  | 5.2 |
Worldwide |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  |  | 15,055 |  |  |  | 15,090 |  |  |  | (0.2 | )
International |  |  | 17,715 |  |  |  | 15,871 |  |  |  | 11.6 |
Total |  | $ | 32,770 |  |  | $ | 30,961 |  |  |  | 5.8 | %
OPERATING PROFIT BY SEGMENT OF BUSINESS
|  | Fiscal Quarters Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
Consumer |  | $ | 549 |  |  | $ | 669 |  |  |  | (17.9 | )%
Pharmaceutical (1) |  |  | 1,714 |  |  |  | 1,833 |  |  |  | (6.5 | )
Medical Devices & Diagnostics (2) |  |  | 1,275 |  |  |  | 1,876 |  |  |  | (32.0 | )
Segments operating profit |  |  | 3,538 |  |  |  | 4,378 |  |  |  | (19.2 | )
Expense not allocated to segments (3) |  |  | (116 | ) |  |  | (158 | ) |  |  |  |
Worldwide income before taxes |  | $ | 3,422 |  |  | $ | 4,220 |  |  |  | (18.9 | )%
|  | Fiscal Six Months Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
Consumer |  | $ | 1,122 |  |  | $ | 1,454 |  |  |  | (22.8 | )%
Pharmaceutical (1) |  |  | 3,923 |  |  |  | 3,803 |  |  |  | 3.2 |
Medical Devices & Diagnostics (2) |  |  | 3,219 |  |  |  | 5,578 |  |  |  | (42.3 | )
Segments operating profit |  |  | 8,264 |  |  |  | 10,835 |  |  |  | (23.7 | )
Expense not allocated to segments (3) |  |  | (332 | ) |  |  | (335 | ) |  |  |  |
Worldwide income before taxes |  | $ | 7,932 |  |  | $ | 10,500 |  |  |  | (24.5 | )%
(1) |  | Includes litigation expense of $290 million and $540 million recorded in the fiscal second quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011 includes a gain related to the Company’s earlier investment in Crucell recorded in the fiscal first quarter of 2011. The fiscal second quarter and the first fiscal six months of 2010, includes net litigation expense of $115 million and $202 million, respectively.
(2) |  | Includes restructuring expense of $676 million recorded in the fiscal second quarter and first fiscal six months of 2011. Includes litigation expense and additional DePuy ASR™ Hip recall costs of $127 million recorded in the fiscal second quarter of 2011. Includes litigation expense and additional DePuy ASR™ Hip recall costs of $223 million recorded in the first fiscal six months of 2011. Includes net litigation expense of $42 million and income of $1,542 million recorded in the fiscal second quarter and the first fiscal six months of 2010, respectively.
(3) |  | Amounts not allocated to segments include interest income/(expense), non-controlling interests and general corporate income/(expense).
SALES BY GEOGRAPHIC AREA
|  | Fiscal Quarters Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
U.S. |  | $ | 7,447 |  |  | $ | 7,438 |  |  |  | 0.1 | %
Europe |  |  | 4,543 |  |  |  | 3,832 |  |  |  | 18.6 |
Western Hemisphere, excluding U.S. |  |  | 1,543 |  |  |  | 1,375 |  |  |  | 12.2 |
Asia-Pacific, Africa |  |  | 3,064 |  |  |  | 2,685 |  |  |  | 14.1 |
Total |  | $ | 16,597 |  |  | $ | 15,330 |  |  |  | 8.3 | %
|  | Fiscal Six Months Ended
|  | July 3, |  | July 4, |  | Percent
(Dollars in Millions) |  | 2011 |  | 2010 |  | Change
U.S. |  | $ | 15,055 |  |  | $ | 15,090 |  |  |  | (0.2 | )%
Europe |  |  | 8,726 |  |  |  | 7,934 |  |  |  | 10.0 |
Western Hemisphere, excluding U.S. |  |  | 2,979 |  |  |  | 2,655 |  |  |  | 12.2 |
Asia-Pacific, Africa |  |  | 6,010 |  |  |  | 5,282 |  |  |  | 13.8 |
Total |  | $ | 32,770 |  |  | $ | 30,961 |  |  |  | 5.8 | %

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration